| Section: Neuroprotection |
| Mechanisms for Inhibition of Neuronal Death |
Back To Section List |
| Chairpersons: Wolf Lagrèze, Germany and Leonard Levin, USA |
Neuroprotection related to maintaining mitochondrial function
Neville Osborne, UK |
Gene therapy and protein-transduction approaches for neuroprotection
Mathias Bähr, Germany |
Neuronal regeneration: What can we learn from the spinal cord?
Irin Maier, Switzerland
|
Novel mechanisms for the pharmacological inhibition of axonally-mediated neuronal death
Keith Martin, UK |
| |
|
High Throughput Screening of
Neuroprotective
Therapies |
Back To Section List |
| Chairpersons: Leonard Levin, USA and Wolf Lagrèze, Germany |
Screening of neuroprotective drugs
Wolf Lagrèze, Germany |
Screening synthetic steroids for neuroprotection of retinal ganglion cells in Glaucoma
Neeraj Agarwal, USA |
Differentiated RGC-5 cells as a model for screening retinal gangion cell neuroprotective therapies
Leonard Levin, USA |
